| pubmed-article:12673886 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12673886 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12673886 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:12673886 | lifeskim:mentions | umls-concept:C0032854 | lld:lifeskim |
| pubmed-article:12673886 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12673886 | lifeskim:mentions | umls-concept:C0023689 | lld:lifeskim |
| pubmed-article:12673886 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:12673886 | lifeskim:mentions | umls-concept:C1623145 | lld:lifeskim |
| pubmed-article:12673886 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:12673886 | lifeskim:mentions | umls-concept:C1561558 | lld:lifeskim |
| pubmed-article:12673886 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:12673886 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:12673886 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:12673886 | pubmed:dateCreated | 2003-4-3 | lld:pubmed |
| pubmed-article:12673886 | pubmed:abstractText | The enzyme folylpolyglutamyl synthetase (FPGS) is involved in the resistance to methotrexate in tumor cell lines. The aim of the present study was to determine the impact of FPGS mRNA expression on resistance to methotrexate therapy in patients with rheumatoid arthritis (RA). | lld:pubmed |
| pubmed-article:12673886 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12673886 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12673886 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12673886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12673886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12673886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12673886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12673886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12673886 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12673886 | pubmed:issn | 0392-856X | lld:pubmed |
| pubmed-article:12673886 | pubmed:author | pubmed-author:VEGAJ GJG | lld:pubmed |
| pubmed-article:12673886 | pubmed:author | pubmed-author:SmolevJ KJK | lld:pubmed |
| pubmed-article:12673886 | pubmed:author | pubmed-author:PirkerRR | lld:pubmed |
| pubmed-article:12673886 | pubmed:author | pubmed-author:PaulP FPF | lld:pubmed |
| pubmed-article:12673886 | pubmed:author | pubmed-author:FilipitsMM | lld:pubmed |
| pubmed-article:12673886 | pubmed:author | pubmed-author:StranzlTT | lld:pubmed |
| pubmed-article:12673886 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12673886 | pubmed:volume | 21 | lld:pubmed |
| pubmed-article:12673886 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12673886 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12673886 | pubmed:pagination | 27-32 | lld:pubmed |
| pubmed-article:12673886 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12673886 | pubmed:meshHeading | pubmed-meshheading:12673886... | lld:pubmed |
| pubmed-article:12673886 | pubmed:meshHeading | pubmed-meshheading:12673886... | lld:pubmed |
| pubmed-article:12673886 | pubmed:meshHeading | pubmed-meshheading:12673886... | lld:pubmed |
| pubmed-article:12673886 | pubmed:meshHeading | pubmed-meshheading:12673886... | lld:pubmed |
| pubmed-article:12673886 | pubmed:meshHeading | pubmed-meshheading:12673886... | lld:pubmed |
| pubmed-article:12673886 | pubmed:meshHeading | pubmed-meshheading:12673886... | lld:pubmed |
| pubmed-article:12673886 | pubmed:meshHeading | pubmed-meshheading:12673886... | lld:pubmed |
| pubmed-article:12673886 | pubmed:meshHeading | pubmed-meshheading:12673886... | lld:pubmed |
| pubmed-article:12673886 | pubmed:meshHeading | pubmed-meshheading:12673886... | lld:pubmed |
| pubmed-article:12673886 | pubmed:meshHeading | pubmed-meshheading:12673886... | lld:pubmed |
| pubmed-article:12673886 | pubmed:meshHeading | pubmed-meshheading:12673886... | lld:pubmed |
| pubmed-article:12673886 | pubmed:meshHeading | pubmed-meshheading:12673886... | lld:pubmed |
| pubmed-article:12673886 | pubmed:meshHeading | pubmed-meshheading:12673886... | lld:pubmed |
| pubmed-article:12673886 | pubmed:meshHeading | pubmed-meshheading:12673886... | lld:pubmed |
| pubmed-article:12673886 | pubmed:meshHeading | pubmed-meshheading:12673886... | lld:pubmed |
| pubmed-article:12673886 | pubmed:meshHeading | pubmed-meshheading:12673886... | lld:pubmed |
| pubmed-article:12673886 | pubmed:articleTitle | Expression of folylpolyglutamyl synthetase predicts poor response to methotrexate therapy in patients with rheumatoid arthritis. | lld:pubmed |
| pubmed-article:12673886 | pubmed:affiliation | Division of Oncology, Department of Internal Medicine I, University of Vienna, Vienna, Austria. | lld:pubmed |
| pubmed-article:12673886 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12673886 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12673886 | lld:pubmed |
